INS and obesity due to melanocortin 4 receptor deficiency: Obesity may elevate the risk of AD through various mechanisms, including chronic inflammation, impaired brain insulin signaling, vascular damage, and hormonal and neurotransmission changes (e.g., leptin and glutamate).